Mesco Pharmaceuticals Ltd. - Research Center
500274 MESPHAR-B Group (ZP) BSE data
Results
Statement
More
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Mar ' 18 |
Mar ' 17 |
Equity share capital
19.74 |
19.74 |
19.74 |
19.74 |
19.74 |
Share application money
Preference share capital
Reserves & surplus
-30.76 |
-30.75 |
-30.65 |
-30.24 |
-30.16 |
Secured loans
Unsecured loans
11.18 |
11.22 |
- |
10.75 |
10.66 |
Total
Gross block
0.18 |
0.18 |
0.18 |
0.18 |
14.22 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
Less : current liabilities & provisions
Total net current assets
-0.01 |
0.02 |
0.02 |
0.03 |
0.03 |
Miscellaneous expenses not written
Total
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
203.21 |
203.21 |
203.21 |
203.21 |
203.21 |